Clinical Trials

Apremilast in psoriasis: The PSOR-003 (Double-Blind, Randomized, Placebo-Controlled Comparison of CC10004 in Subjects With Moderate to Severe Plaque Type Psoriasis; NCT00606450) study

Double-blind, randomized, placebo-controlled comparison of CC10004 in subjects with moderate to severe plaque type psoriasis (PSOR-003) (NCT00606450)

to Continue Reading, Login Now

Please Login

If you are a registered user but you have forgotten your password, please click here
If you are not a registered user, please register here